Ultrasound-Guided Sclerotherapy of the Great Saphenous Vein with 1% vs. 3% Polidocanol Foam: A Multicentre Double-Blind Randomised Trial with 3-Year Follow-Up

This publication has 14 references indexed in Scilit:

• Efficacy of Polidocanol Foam versus Liquid in Sclerotherapy of the Great Saphenous Vein: A Multicentre Randomised Controlled Trial with a 2-year Follow-up
  European Journal of Vascular and Endovascular Surgery, 2008
• Efficacy and Safety of Great Saphenous Vein Sclerotherapy Using Standardised Polidocanol Foam (ESAF): A Randomised Controlled Multicentre Clinical Trial
  European Journal of Vascular and Endovascular Surgery, 2008
• Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2^ndEuropean Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany
  Vasa, 2008
• Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided Sclerotherapy of the Great Saphenous Vein: A Randomised, Double-Blind Trial with 2 Year-Follow-up. “The 3/1 Study”
  European Journal of Vascular and Endovascular Surgery, 2007
• Systematic review of foam sclerotherapy for varicose veins
  British Journal of Surgery, 2007
• Varisolve^® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial
  Phlebology: The Journal of Venous Disease, 2006
• Efficacy and Safety of Sclerotherapy Using Polidocanol Foam: A Controlled Clinical Trial
  Published by Elsevier ,2005
• Stability of Foam in Sclerotherapy
  Dermatologic Surgery, 2005
• Venous severity scoring: An adjunct to venous outcome assessment
  Journal of Vascular Surgery, 2000
• Construction and validation of a quality of life questionnaire in Chronic Lower Limb Venous Insufficiency (CIVIQ)
  Quality of Life Research, 1996